These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22843195)

  • 21. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis.
    Ayoub K; Nairooz R; Almomani A; Marji M; Paydak H; Maskoun W
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2215-21. PubMed ID: 27289185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
    Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH
    Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients.
    Gratz J; Pausch A; Schaden E; Baierl A; Jaksch P; Erhart F; Hoetzenecker K; Wiegele M
    Artif Organs; 2020 Jun; 44(6):638-646. PubMed ID: 31951030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding.
    Eijgenraam P; ten Cate H; ten Cate-Hoek AJ
    Neth J Med; 2014 Apr; 72(3):157-64. PubMed ID: 24846933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.
    Leijtens B; Kremers van de Hei K; Jansen J; Koëter S
    Arch Orthop Trauma Surg; 2014 Sep; 134(9):1335-41. PubMed ID: 24990654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant bridging in left-sided mechanical heart valve patients.
    Hart EA; Jansen R; Meijs TA; Bouma BJ; Riezebos RK; Tanis W; van Boven WJ; Hindori V; Wiersma N; Dessing T; Westerink J; Chamuleau SA
    Int J Cardiol; 2017 Apr; 232():121-126. PubMed ID: 28089150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Svensson PJ; Själander A
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):961-966. PubMed ID: 28468510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings.
    Nikolakopoulos I; Spyropoulos AC
    Semin Thromb Hemost; 2020 Feb; 46(1):26-31. PubMed ID: 31830765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peri-procedural antithrombotic management: time to burn the bridge?
    Marquez J; Togami JC; Dant CR; Herrera A; Marshik P; Burnett AE
    J Thromb Thrombolysis; 2018 Apr; 45(3):337-344. PubMed ID: 29383558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
    Hammerstingl C; Omran H
    Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis.
    Passaglia LG; de Barros GM; de Sousa MR
    J Thromb Haemost; 2015 Sep; 13(9):1557-67. PubMed ID: 26178802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of educational intervention on management of periprocedural anticoagulation.
    Awker AL; Bell MA; McGraw M; Klein MA
    Am J Health Syst Pharm; 2017 Dec; 74(23 Supplement 4):S95-S101. PubMed ID: 29167146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
    Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
    JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
    van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
    J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periprocedural Management of Oral Anticoagulation.
    Shaw JR; Kaplovitch E; Douketis J
    Med Clin North Am; 2020 Jul; 104(4):709-726. PubMed ID: 32505262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.